tradingkey.logo

Nanovibronix Inc

NAOV
4.020USD
0.0000.00%
收盤 02/06, 16:00美東報價延遲15分鐘
4.06M總市值
虧損本益比TTM

Nanovibronix Inc

4.020
0.0000.00%

關於 Nanovibronix Inc 公司

NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.

Nanovibronix Inc簡介

公司代碼NAOV
公司名稱Nanovibronix Inc
上市日期Apr 24, 2015
CEOBesser (Doron)
員工數量15
證券類型Ordinary Share
年結日Apr 24
公司地址969 Pruitt Piace
城市TYLER
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編75703
電話19142333004
網址https://nanovibronix.com/
公司代碼NAOV
上市日期Apr 24, 2015
CEOBesser (Doron)

Nanovibronix Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
2.00
--
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Stephen Russell (Steve) Brown
Mr. Stephen Russell (Steve) Brown
Chief Financial Officer
Chief Financial Officer
2.00
--
Dr. Harold Jacob, M.D.
Dr. Harold Jacob, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Doron Besser, M.D.
Dr. Doron Besser, M.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Prof. Zeev Rotstein
Prof. Zeev Rotstein
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
462.00K
93.52%
New Zealand
20.00K
4.05%
Europe
8.00K
1.62%
Other
4.00K
0.81%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 1月2日 週五
更新時間: 1月2日 週五
持股股東
股東類型
持股股東
持股股東
佔比
Alpha Capital Aktiengesellschaft
0.76%
Geode Capital Management, L.L.C.
0.49%
Armistice Capital LLC
0.37%
Morgan Stanley Smith Barney LLC
0.09%
Tower Research Capital LLC
0.06%
其他
98.23%
持股股東
持股股東
佔比
Alpha Capital Aktiengesellschaft
0.76%
Geode Capital Management, L.L.C.
0.49%
Armistice Capital LLC
0.37%
Morgan Stanley Smith Barney LLC
0.09%
Tower Research Capital LLC
0.06%
其他
98.23%
股東類型
持股股東
佔比
Holding Company
0.76%
Investment Advisor/Hedge Fund
0.49%
Hedge Fund
0.42%
Investment Advisor
0.11%
其他
98.21%

機構持股

更新時間: 1月1日 週四
更新時間: 1月1日 週四
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
17
11.24K
1.03%
+4.25K
2025Q3
17
5.95K
0.68%
+2.34K
2025Q2
26
142.96K
5.53%
+80.02K
2025Q1
26
100.49K
7.64%
+70.73K
2024Q4
29
390.46K
7.75%
-206.57K
2024Q3
31
421.26K
15.22%
+83.76K
2024Q2
31
243.60K
8.84%
-214.51K
2024Q1
34
373.91K
18.23%
+170.33K
2023Q4
38
117.62K
5.71%
-262.96K
2023Q3
41
131.29K
7.90%
-1.54K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Alpha Capital Aktiengesellschaft
8.25K
0.76%
+4.93K
+148.55%
May 16, 2025
Geode Capital Management, L.L.C.
5.14K
0.47%
--
--
Nov 30, 2025
Armistice Capital LLC
3.99K
0.37%
+3.99K
--
Mar 31, 2025
Morgan Stanley Smith Barney LLC
1.00K
0.09%
+1.00K
--
Sep 30, 2025
Tower Research Capital LLC
627.00
0.06%
+401.00
+177.43%
Sep 30, 2025
The Vanguard Group, Inc.
189.00
0.02%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
35.00
0%
-1.33K
-97.45%
Sep 30, 2025
Fashek (Christopher M)
34.00
0%
--
--
Oct 27, 2025
SBI Securities Co., Ltd.
15.00
0%
+15.00
--
Sep 30, 2025
BofA Global Research (US)
6.00
0%
+5.00
+500.00%
Sep 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
Aug 08, 2025
Merger
10→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
公告日期
除權除息日
類型
比率
Aug 08, 2025
Merger
10→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 25, 2025
Merger
11→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
Feb 08, 2023
Merger
20→1
KeyAI